Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neurocrine Biosciences Inc (NASDAQ:NBIX)

33.69
Delayed Data
As of 3:59pm ET
 +1.50 / +4.66%
Today’s Change
31.25
Today|||52-Week Range
58.46
-40.45%
Year-to-Date

Today’s Trading

Previous close32.19
Today’s open33.35
Day’s range33.35 - 36.27
Volume1,886,030
Average volume (3 months)1,179,155
Market cap$2.8B
Dividend yield--
Data as of 3:59pm ET, 02/10/2016

Growth & Valuation

Earnings growth (last year)-17.39%
Earnings growth (this year)-27.34%
Earnings growth (next 5 years)-9.18%
Revenue growth (last year)-100.00%
P/E ratioNM
Price/Sales--
Price/Book11.79

Competitors

 Today’s
change
Today’s
% change
AKRXAkorn Inc-0.27-1.10%
CBPOChina Biologic Produ...+0.40+0.37%
ANACAnacor Pharmaceutica...+0.66+0.99%
HZNPHorizon Pharma PLC+0.07+0.43%
Data as of 3:59pm ET, 02/10/2016

Financials

Next reporting dateFebruary 12, 2016
EPS forecast (this quarter)-$0.32
Annual revenue (last year)$0.00
Annual profit (last year)-$60.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Kevin Charles Gorman
Vice President-Information Technology &
Operations
Bill Wilson
Corporate headquarters
San Diego, California

Forecasts

Partner Offers